Keywords:
Benign prostatic hyperplasia, immunology, transurethral resection of the prostate, IPSS, QOL.References
Abrams P. Bladder outlet obstruction index, bladder contractility index and bladder voiding efficiency: three simple indicators to define bladder voiding function // BJU Int. 1999. Vol. 84, No. 4. P. 745-750.
Abrams P., Cardozo L., Fall M., Griffiths D., Rosier P., Ulm-sten U., van Kerrebroeck P., Victor A., Wein A. The standardization of terminology in lower urinary tract function: report from the Standardization Sub-committee of the International Continence Society // Neurourol. Urodynam. 2002. Vol. 21, No. 2. P. 167-178.
Al-Shukri S. Kh. Amdi RE Diagnostics of infravesical obstruction in patients with prostate adenoma // Urology. 2006. No. 2. P. 41-43.
Al-Shukri S. Kh., Kuzmin I. V., Amdiy R. E. Complex treatment of patients with detrusor instability // Urology. 2001. No. 5. P. 26-29 [Al-Shukri S. Kh., Kuzmin I. V., Amdiy R. E. Complex treatment of patients with detrusor instability // Urology. 2001. No. 5. P. 26-29].
Amdiy RE, Giorgobiani TG Symptoms of the lower urinary tract and decreased detrusor contractility in patients with BPH // Urologicheskie vedomosti. 2015. Vol. 5, No. 1. P. 77.
Chapple C., Osman N., Birder L., van Koeveringe G., Oelke M., Nitti V., Drake M., Yamaguchi O., Abrams P., Smith P. The underactive bladder: a new clinical concept? //Eur. Urol. 2015. Vol. 68, No. 3. P. 351-353.
Donohue JF, Sharma H., Abraham R., Natalwala S., Thomas DR, Foster MC Transurethral prostate resection and bleeding: A randomized, placebo-controlled trial of the role of finasteride for decreasing operative bloodloss. J Urol. 2002; 168 (5): 2024-2026.
Foley SJ and Bailey DM: Micro vessel density in prostatic hyperplasia. BJU Int, 85: 70, 2000.
Giorgobiani TG, Amdi RE Urination disorders in patients with unsatisfactory results of surgical treatment of benign prostatic hyperplasia // Nephrology. 2015. Vol. 19, No. 4. P. 112-117.
Han HH, Ko WJ, Yoo TK Factors associated with continuing medical therapy after transurethral resection of prostate // Urology. 2014. Vol. 84, No. 3. P. 675-680.
Lepor H. Pathophysiology, epidemiology and natural history of benign prostatic hyperplasia. Rev in Urol 2004; 6 (Suppl 9): 310.
Pareek G., Shevchuk M., Armenakas NA et al. The effect of finasteride on the expression of vascular endothelial growth factor and micro vessel density: A possible mechanism for decreased prostatic bleeding in treated patients. J Urol. 2003; 169(1): 20-23.
Reich O., Gratzke C., Bachmann A. et al. UrologySection of the Bavarian Working Group for Quality Assurance. Morbidity, mortality and early outcome of transurethral resection of the prostate: A prospective multicenter evaluation of 10,654 patients. J Urol. 2008; 1806(1): 246-249.
Sandfeldt L., Bailey DM, Hahn RG Blood loss during transurethral resection of the prostate after 3 months of treatment with finasteride. Urology. 2001; 58 (6): 972-976.
Thomas AW, Cannon A., Bartlett E., Ellis-Jones J., Abrams P. The natural history of lower urinary tract dysfunction in men: the influence of detrusor underactivity on the outcome after transurethral resection of the prostate with a minimum 10-year urodynamic follow-up // BJU Int. 2004. Vol. 93, No. 6. P. 745-750.
Woo MJ, Ha Y, Lee JN, Kim BS, Kim HT, Kim T., Yoo ES Comparison of surgical outcomes between holmium laser enucleation and transurethral resection of the prostate in patients with detrusor underactivity // International Neurourol. J. 2017, No. 21. P. 46-52.